Additional clearance furthers Eclipse product growth of popular platelet-rich plasma kits
DALLAS, June 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, announced it is expanding its Eclipse PRP® product line in Canada.
Recently, Health Canada cleared Eclipse PRP® (Health Canada Lic.#99292) products. The company is now offering Eclipse PRP® HC featuring a 22 mL high-concentration tube. The HC tube yields an average of ~11 mL of platelet-rich plasma. The Eclipse PRP® system is also available with the standard 11 mL tube that yields approximately ~6 mL of PRP.
Both tubes can be processed from the Eclipse Easy Spin™ Centrifuge (Health Canada Lic.#99293). Equipped with custom fit tube holders, the centrifuge offers PRP providers the flexibility to process 22 mL or 11 mL tubes from one unit.
Eclipse PRP® is an autologous system that allows for the safe preparation of pure PRP with optimal platelet recovery or 87% ± 10%. Virtually, all red blood cells (RBC) are eliminated from PRP for reduced inflammation. The concentration of pro-inflammatory Granulocytes (GRs) are also highly reduced. This system has been safely used in hundreds of thousands of procedures worldwide.
“Eclipse PRP® products are global best sellers. The system is fast, effective, simple to use, requires minimal steps, and allows for customizable concentration,” said Tom O’Brien, CEO and Founder of Eclipse. “Our company is pleased to now provide the 22 mL PRP kit along with the 11 mL PRP kit to practices in Canada though our distribution partner Salient Medical Solutions.”
“Both tubes offer an incredible value providing both quantity and quality,” said Jay Herman, President of Salient Medical Solutions. “Eclipse PRP® is an innovative system that is not only easy to use, it is available at a lower price per mL when compared to many other PRP kits on the market.”
Eclipse PRP® has been featured in U.S. and International media for its leading-edge cellular collection technology and remarkable results. Read More